Stockholm Medical Cannabis Conference

The Upcoming Unavoidable Divergence of the Medical and Recreational Cannabis Markets

Medical and recreational cannabis markets are likely to diverge further as scientific research reveals more therapeutic benefits of cannabis and its derivatives. This divergence stems from the demand for specific, evidence-based treatments for various medical conditions, which require accurate dosing, controlled formulations, and strict quality standards. On the other hand, recreational cannabis products are mainly designed for consumer satisfaction and preferences, with a wider range of product types and a continuous focus on THC potencies.

The main reason behind most Doctors’ reluctance to Medical Cannabis – and what needs to change.

Despite the growing acceptance of medical cannabis among the public, most doctors remain reluctant to recommend it to their patients due to a lack of understanding of the endocannabinoid system (ECS) and the role it plays in mediating the effects of cannabis in the body. The ECS is a complex regulatory system that plays a fundamental role in regulating a wide range of physiological processes, including appetite, pain sensation, mood, and immune function. Medical schools and universities should incorporate information about the ECS and medical cannabis into their curricula, and healthcare professionals should receive ongoing education and training to stay up-to-date with the latest research and prescribing guidelines.

Medical Cannabis: Finding the Sweet Spot Between Therapeutic Benefits and Adverse Effects 

Explore the complexities of finding the optimal dosage and administration of medical cannabis. This comprehensive review dives into various factors such as the individual’s medical condition, age, and genetics, the plant’s biphasic properties, and the need for standardized quality-controlled products. Discover the balance between maximizing therapeutic benefits while minimizing potential adverse effects.